TR antagonist 2 (Compound 10a) is a competitive thyroid hormone receptors (TRalpha/beta) antagonist (IC50=47 nM). TR antagonist 2 competes with triiodothyronine (T3) for binding to the ligand-binding domain of TR to block receptor-coactivator complex formation and inhibit target gene transcription, reducing thyroid hormone-mediated hypermetabolic effects. TR antagonist 2 is promising for research of hyperthyroidism (e.g., Graves disease) and thyrotoxicosis[1].
Molekulargewicht:
463.41
Reinheit:
98.94
CAS Nummer:
[1073179-55-1]
Formel:
C21H20F3N5O4
Target-Kategorie:
Thyroid Hormone Receptor
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten